project id: TCGA-OV; case submitter id: TCGA-24-2289; selected normal wgs: true; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.1; rna integrity number: 7.1; spectrophotometer method: UV Spec; age at index: 68; days to birth: -25191; days to death: 2049; ethnicity: not reported; gender: female; race: white; vital status: Dead; year of birth: 1929; year of death: 2002; age at diagnosis: 25191; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2049.0; figo stage: Stage IV; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 1997; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 1.0; longest dimension: 1.5; preservation method: Unknown; shortest dimension: 0.4; sample id: f39ab685-fda1-43e8-aa70-fa3ed1566061; sample submitter id: TCGA-24-2289-01A; portion id: e4c845a5-946a-4723-854d-7b6ad1212418; portion submitter id: TCGA-24-2289-01A-01; percent necrosis: 1.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 89.0; percent tumor nuclei: 90.0;